Filter by

  • Publication Year
  • Availability
  • Attachment
  • Collection Type
    See More
  • General Material Designation
    See More
  • Location
    See More
  • Language
Found 6 from your keywords: subject="Thrombosis"
cover
Apixaban enhances endogenous fibrinolysis in patients with atrial fibrillation
Comment Share
Spinthakis N

In a prospective cross-sectional analysis, we compared endogenous fibrinolysis in NVAF patients (n = 180) taking aspirin, warfarin, or apixaban. In a prospective longitudinal study, patients were tested before and after apixaban (n = 80). Endogenous fibrinolysis was assessed using the Global Thrombosis Test (GTT) and thromboelastography (TEG). Endogenous fibrinolysis [measured by GTT lysis time…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
cover
Deep venous thrombosis: a literature review
Comment Share
Abdulrahman Abas Osman

Abstract: Deep vein thrombosis (DVT) refers to the formation of thrombosis within the deep veins, dominantly occurring in the pelvis or lower limbs. This clinical syndrome has gained attention as one complication of DVT, pulmonary embolization, can be fatal. Therefore, early detection and systematic management of DVT and related complica tions are essential in clinical practice. As the clinica…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
cover
Clopidogrel : A Review of its Use in the Prevention of Thrombosis
Comment Share
Plosker GL

Clopidogrel (Plavix®, Iscover®) selectively and irreversibly inhibits adenosine diphosphate (ADP)-induced platelet aggregation. Long-term administration of clopidogrel was associated with a modest but statistically significant advantage over aspirin in reducing adverse cardiovascular outcomes in patients with established cardiovascular disease in the CAPRIE trial. In other large well designed…

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
cover
Clopidogrel : A Review of its Use in the Prevention of Atherothrombosis
Comment Share
Jarvis B

Clopidogrel is an ADP receptor antagonist that is indicated for the reduction of atherosclerotic events including myocardial infarction, ischaemic stroke and vascular death in patients with atherosclerosis manifested by recent stroke, myocardial infarction or established peripheral vascular disease

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
cover
Diagnosis dan Tatalaksana Deep Vein Thrombosis
Comment Share
Jayanegara AP

Deep vein thrombosis (DVT) adalah bekuan darah di vena dalam yang sebagian besar tersusun atas fibrin, sel darah merah, serta sebagian kecil komponen leukosit dan trombosit. Diagnosis DVT ditegakkan berdasarkan gejala klinis dan pemeriksaan penunjang berupa laboratorium dan radiologi. Penatalaksanaan DVT dapat berupa terapi non-farmakologis, farmakologis, ataupun pembedahan

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-
cover
Fondaparinux or Enoxaparin for the Initial Treatment of Symptomatic Deep Veno…
Comment Share
Buller HR

The current standard initial therapies for deep venous thrombosis are low-molecular-weight heparin and unfractionated heparin. In a dose-ranging study of patients with symptomatic deep venous thrombosis, fondaparinux had efficacy and a safety profile similar to those of low-molecular-weight heparin (dalteparin)

Edition
-
ISBN/ISSN
-
Collation
-
Series Title
-
Call Number
-